{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:16:56Z","timestamp":1775027816892,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971197"],"award-info":[{"award-number":["81971197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Ningxia Hui Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AAC02072"],"award-info":[{"award-number":["2024AAC02072"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2700803"],"award-info":[{"award-number":["2021YFC2700803"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nbd.2025.106899","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:35:35Z","timestamp":1744036535000},"page":"106899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes"],"prefix":"10.1016","volume":"209","author":[{"given":"Shuxia","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106899_bb0005","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106899_bb0010","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of \u03b1-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106899_bb0015","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106899_bb0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106899_bb0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid \u03b2-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter \u03b1-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106899_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.nbd.2025.106899_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/hum.2018.072","article-title":"Delivery of Glucosylceramidase Beta gene using AAV9 vector therapy as a treatment strategy in mouse models of Gaucher disease","volume":"30","author":"Du","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2025.106899_bb0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179126","article-title":"Deletion of Gba in neurons, but not microglia, causes neurodegeneration in a Gaucher mouse model","volume":"9","author":"Duffy","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.nbd.2025.106899_bb0045","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106899_bb0050","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106899_bb0055","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.008185","article-title":"Animal models for Gaucher disease research","volume":"4","author":"Farfel-Becker","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2025.106899_bb0060","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106899_bb0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106899_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.892457","article-title":"Establishment and phenotypic analysis of the novel Gaucher disease mouse model with the partially humanized Gba1 gene and F213I mutation","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.nbd.2025.106899_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104513","article-title":"Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease","volume":"130","author":"Jackson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106899_bb0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.106899_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6393","article-title":"Mutant glucocerebrosidase impairs alpha-synuclein degradation by blockade of chaperone-mediated autophagy","volume":"8","author":"Kuo","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2025.106899_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106899_bb0095","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106899_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: from human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2025.106899_bb0105","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpeds.2009.07.004","article-title":"Recommendations on diagnosis, treatment, and monitoring for Gaucher disease","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.106899_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106899_bb0115","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/brain\/awx221","article-title":"The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice","volume":"140","author":"Migdalska-Richards","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106899_bb0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"Qjm"},{"key":"10.1016\/j.nbd.2025.106899_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106899_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101939","article-title":"Brain pathology and cerebellar purkinje cell loss in a mouse model of chronic neuronopathic Gaucher disease","volume":"197","author":"Pewzner-Jung","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106899_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2025.106899_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease - more than just a rare lipid storage disease","volume":"100","author":"Roh","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.nbd.2025.106899_bb0145","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106899_bb0150","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mdc3.13031","article-title":"Parkinsonism in patients with neuronopathic (type 3) Gaucher disease: a case series","volume":"7","author":"Ryan","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.nbd.2025.106899_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106899_bb0160","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2025.106899_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106899_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1096-7192(02)00114-2","article-title":"Prosaposin: threshold rescue and analysis of the \u201cneuritogenic\u201d region in transgenic mice","volume":"76","author":"Sun","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2025.106899_bb0175","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106899_bb0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher\u2019s disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106899_bb0185","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106899_bb0190","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2025.106899_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2008.01.013","article-title":"Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels","volume":"94","author":"Xu","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2025.106899_bb0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of \u03b1-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2025.106899_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"\u0391-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106899_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40035-024-00437-6","article-title":"Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.nbd.2025.106899_bb0215","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s13760-024-02493-1","article-title":"A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment","volume":"124","author":"Zhong","year":"2024","journal-title":"Acta Neurol. Belg."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.106899_bb0220","first-page":"82","article-title":"Management of Gaucher disease: enzyme replacement therapy","volume":"12","author":"Zimran","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T10:55:44Z","timestamp":1745232944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0969996125001159"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106899","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106899"}}